Higher-Order Structure Comparability

摘要

Case Studies of Biosimilar Monoclonal Antibodies. Great successes for monoclonal antibody (MAb)-based biologies over the past decade have provided many valuable options for patients combating some of the most serious diseases in the world, including cancer and autoimmune diseases. MAbs and antibody—drug conjugates (ADCs) are among the fastest growing biologic segments in development, with hundreds of candidates currently under clinical study.